ISLET TRANSPLANTATION IN TYPE 1 DIABETICS USING AN IMMUNOSUPPRESSIVE PROTOCOL BASED ON THE ANTI-LFA-1 ANTIBODY EFALIZUMAB

The applicability of islet transplantation as treatment for type 1 diabetes is limited by renal and islet toxicities of currently available immunosuppressants. We describe a novel immunosuppressive regimen using the anti-leukocyte functional antigen-1 antibody efalizumab which permits long-term isle...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Posselt, Andrew M., Bellin, Melena D., Tavakol, Mehdi, Szot, Gregory L., Frassetto, Lynda A., Masharani, Umesh, Kerlan, Robert K., Fong, Lawrence, Vincenti, Flavio G., Hering, Bernhard J., Bluestone, Jeffrey A., Stock, Peter G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2911648/
https://ncbi.nlm.nih.gov/pubmed/20659093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2010.03073.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados